Substituent effects on electronic properties and predicted acetylcholinesterase binding potential of donepezil analogues: a DFT, molecular docking, and ADMET study with dynamics assessment of the lead candidate
Authors: Ejaz, Muhammad Mohsin; Iftikhar, Hamza; Al-Namshah, K S; Khan, Saira; Ashraf, Sadaf; Meer, Nazia; Riaz, Musarat; Saleem, Muhammad; Khan, Muhammad Shar Jhahan
Source journal: In silico pharmacology (2026-01-01)
DOI: 10.1007/s40203-026-00786-2
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is the most common cause of dementia in older people. Donepezil is an acetylcholinesterase inhibitor used for symptomatic management of AD. Due to its clinically established AChE inhibition; it was used as a reference. In this study, a series of donepezil derivatives (MH-1 to MH-5) were designed by introducing a para substituent (NH(2), NO(2), Cl, OH or OCH(3)) on the benzyl moiety and systematically investigated along with the R using density functional theory, time-dependent DFT, molecular docking, and in silico pharmacokinetics analysis. The geometry optimization and electronic structure calculations were performed using the B3LYP/6-311G (d, p) level. Frontier molecular orbital analysis indicated reduced energy gaps in MH-1 and MH-2. The in silico molecular docking analysis of all derivatives and the R was performed against the acetylcholinesterase receptor (PDB ID 4EY7), where MH-1, MH-2, and MH-4 showed Vina scores equal to the R (- 12.2 kcal/mol). MH-4 was selected for a single 300 ns molecular dynamics simulation (unlike MH-1 and MH-2, it had no predicted mutagenicity alert). The protein backbone RMSD stayed mostly between 0.15 and 0.22 nm, and the ligand stayed in contact with the protein while changing its conformation and orientation. MM-GBSA enthalpy was stable across sampling densities (DeltaH approximately -24.6 kcal/mol), whereas the Interaction Entropy-corrected binding free energy varied with the number of frames analysed (DeltaG = - 9.76 to - 15.71 kcal/mol, standard error approximately 3.7-4.0 kcal/mol). Moreover, ADMETlab 3.0 predicted high intestinal absorption. ProTox 3.0 predicted several toxicity alerts for all compounds, including immunotoxicity and respiratory toxicity; MH-1 and MH-2 were also flagged for mutagenicity. In summary, MH-4 is proposed as a candidate for experimental evaluation. All results are computational predictions and require experimental validation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at https://doi.org/10.1007/s40203-026-00786-2.
Related topics
Related open access articles
- Development and Validation Molecular Docking Analysis of Human serum albumin (HSA)
- Facing COVID-19 via anti-inflammatory mechanism of action: Molecular docking and Pharmacokinetic studies of six anti-inflammatory compounds derived from Passiflora edulis
- Computational analysis by molecular docking of thirty alkaloid compounds from medicinal plants as potent inhibitors of SARS-CoV-2 main protease
- Curcumin and pipernonaline to curb diabetes the natural way: A molecular modeling, docking and dynamics simulation study
- DENSITY FUNCTIONAL THEORY ANALYSIS AND MOLECULAR DOCKING EVALUATION OF 8-CHLOROQUINOLINE 2-CARBALDEHYDE
- Thermochemical, DFT, Molecular Docking and Pharmacokinetic Studies of Methyl β-D-galactopyranoside Esters
Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.